| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |